Is the Aspergillus antigen the same as galactomannan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Aspergillus antigen and galactomannan are the same thing

Galactomannan (GM) is the specific Aspergillus antigen that is detected in clinical testing for invasive aspergillosis. When clinicians refer to "Aspergillus antigen testing," they are specifically talking about galactomannan detection 1.

What Galactomannan Is

Galactomannan is a polysaccharide component of the Aspergillus cell wall that gets released into blood and body fluids during invasive infection 2. The molecule consists of:

  • A 1→6-linked mannan backbone
  • Oligogalactoside side chains (typically 3 units long)
  • Terminal galactofuranose residues that serve as antigenic determinants
  • A galactose to mannose ratio of approximately 1:1.17 3

The molecular weight ranges from 25,000 to 75,000 daltons 3.

Clinical Testing

The standard commercial assay (Platelia® Aspergillus) uses a double-sandwich ELISA method to detect galactomannan in serum, bronchoalveolar lavage (BAL), cerebrospinal fluid, and other body fluids 2. This is what is meant when ordering "Aspergillus antigen" testing.

Key Performance Characteristics:

  • Sensitivity: 80-100% in granulocytopenic patients 2
  • Specificity: 90-100% 2
  • Negative predictive value: >90% 2
  • Current cut-off for positivity: optical density index ≥0.5 in two consecutive samples 2

Important Distinction from Other Tests

Do not confuse galactomannan testing with:

  • β-D-glucan (BDG): A different fungal cell wall component that detects multiple fungi (Candida, Aspergillus, Fusarium, Pneumocystis) but is NOT specific for Aspergillus 2
  • Aspergillus antibody testing: Detects host immune response (IgG antibodies), useful in chronic pulmonary aspergillosis but NOT in acute invasive disease in immunocompromised patients 1

The galactomannan test detects only Aspergillus species (and occasionally cross-reacts with Penicillium or Histoplasma), whereas β-D-glucan is pan-fungal 4, 2.

Clinical Caveats

False Positives:

  • Piperacillin-tazobactam and certain β-lactam antibiotics (up to 8% of samples) 2
  • Cross-reactivity with other fungi in rare cases 5

False Negatives:

  • Concurrent mold-active antifungal therapy 4
  • Corticosteroid use (may suppress antigen release) 1

Optimal Testing Strategy:

  • Serial testing at least twice weekly due to transient circulation 2
  • BAL fluid testing superior to serum for pulmonary disease 1, 6
  • Higher sensitivity in neutropenic patients with extensive angio-invasive growth 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.